Who’s Holding Your Ladder?
On 7 May 2022, Assoc Prof Jacqueline Boyle (EHCS) and Prof Sue Walker (Mercy Perinatal) convened a symposium on women in health, research and leadership titled ‘Who's Holding Your Ladder?’.
What Happens Next?: Are We Lonelier Than Ever?
Many of us have emerged from two years of social isolation and physical distancing with a new understanding of what it means to be lonely.
Statewide Mental Health and Addiction Service to be run by Turning Point
Turning Point has been appointed as Victoria’s new Statewide Specialist Service for people living with mental illness and substance use or addiction.
New app helping to reduce alcohol consumption
Harmful levels of alcohol consumption is a major health concern that is linked with chronic disease, injury and mortality, however, a recent trial involving the SWiPE app provided participants with a reduction in their consumption, drinking days and
It’s time to decriminalise personal drug use. Here’s why
The global “War on Drugs” is one of the single-most catastrophic public policy failures in history.
Faculty educators awarded for their innovation and excellence
We are delighted to announce that a number of our Faculty educators were recognised as part of the 2021 Australian Awards for University Teaching (AAUT).
$1.46m NHMRC funding to support bringing research to life
Two Monash researchers have received federal government funding to progress their projects towards the development of treatments for blocked arteries, and intravenous drug delivery in stroke patients.
Free-of-charge naloxone would save lives
New research from the Monash Addiction Research Centre and Burnet Institute demonstrates that making the opioid overdose antidote naloxone easily accessible and available free-of-charge to people who are prescribed opioids in Australia would be
Research shines a light on patients’ experiences of a new treatment for opioid dependence
A recent study led by Turning Point at Monash University and The University of Sydney, has found that a new treatment for opioid dependence, long-acting injectable buprenorphine, may have a range of benefits for patients and be